News
STME
0.295
NaN%
--
Weekly Report: what happened at STME last week (0608-0612)?
Weekly Report · 1h ago
Weekly Report: what happened at STME last week (0601-0605)?
Weekly Report · 06/08 10:28
Weekly Report: what happened at STME last week (0525-0529)?
Weekly Report · 06/01 10:34
Weekly Report: what happened at STME last week (0518-0522)?
Weekly Report · 05/25 10:37
Weekly Report: what happened at STME last week (0511-0515)?
Weekly Report · 05/18 10:37
Stonegate initiates coverage on StimCell Energetics OTCQB: STME
PUBT · 05/15 16:23
Weekly Report: what happened at STME last week (0504-0508)?
Weekly Report · 05/11 10:33
Weekly Report: what happened at STME last week (0427-0501)?
Weekly Report · 05/04 10:30
Weekly Report: what happened at STME last week (0420-0424)?
Weekly Report · 04/27 10:34
Weekly Report: what happened at STME last week (0413-0417)?
Weekly Report · 04/20 10:29
Weekly Report: what happened at STME last week (0406-0410)?
Weekly Report · 04/13 10:34
Stimcell Energetics Q3 net loss narrows 35.6% to $90,566; revenue none
Reuters · 04/10 19:41
Weekly Report: what happened at STME last week (0330-0403)?
Weekly Report · 04/06 10:34
Weekly Report: what happened at STME last week (0323-0327)?
Weekly Report · 03/30 10:34
Weekly Report: what happened at STME last week (0316-0320)?
Weekly Report · 03/23 10:30
StimCell Energetics hires Stonegate Capital Partners for research coverage and investor outreach
Reuters · 03/19 13:15
Weekly Report: what happened at STME last week (0309-0313)?
Weekly Report · 03/16 10:29
Weekly Report: what happened at STME last week (0302-0306)?
Weekly Report · 03/09 10:30
Weekly Report: what happened at STME last week (0223-0227)?
Weekly Report · 03/02 10:29
Weekly Report: what happened at STME last week (0216-0220)?
Weekly Report · 02/23 10:29
More
Webull provides a variety of real-time STME stock news. You can receive the latest news about Stimcell Energetics through multiple platforms. This information may help you make smarter investment decisions.
About STME
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.